ZZS logo

ZS Unclaimed

Management Consulting

www.zs.com

Global management consulting and technology firm delivering data-driven insights and transformation.

ZS is a global management consulting and technology firm that partners with companies to improve life and how we live it. By combining data, science, technology and human ingenuity, ZS helps clients turn ideas into impact and deliver practical, measurable outcomes across industries. The firm serves healthcare, life sciences, consumer goods, technology and other sectors, offering end-to-end capabilities that integrate strategy, data and technology to drive transformation and growth.

We strive to deliver healthy and sustainable outcomes, prioritizing responsible business practices in our work, partnerships and operations.

What we offer

ZAIDYN Platform

Transform life sciences operations with integrated data and AI-driven insights for faster, smarter decisions.

www.zs.com/products/zaidyn-platform

ZS Atlas Intelligence

Unlock consumer-driven insights for faster, informed decisions and market growth.

www.zs.com/products/atlas-intelligence

Personalize.AI

Unlock up to 25% revenue growth through unified AI-driven customer personalization.

www.zs.com/products/personalize-ai

Trials.AI

Enhance clinical trial efficiency with AI-driven automation and real-time insights.

www.zs.com/products/zs-trials-ai

Market segments

Market size by segment

Growth potential (CAGR)

Customer data platform

9.72 Billion USD33.8% CAGR

Capabilities that unify loyalty, interaction and campaign data to build a 360-degree customer profile for identity resolution, segmentation and activation.

Personalization and experience orchestration

12.5 Billion USD22.5% CAGR

Real-time AI-driven personalization, experimentation and campaign automation to deliver hyper-personalized offers, optimize content and improve conversion and retention.

Clinical trial automation and optimization

2 Billion USD21.4% CAGR

Automation, intelligent trial design, document digitization and real-time analytics to speed trial delivery, reduce manual effort and improve study outcomes.

Consumer and patient insight analytics

10 Billion USD19% CAGR

Extraction, theme discovery and prioritization of consumer and patient sentiment from unstructured online and enterprise sources to produce actionable insights and faster research delivery.

More information about our offering

ZAIDYN Platform

ZAIDYN Platform is an AI-powered life sciences platform that unifies data, analytics and workflows across commercial, medical and patient teams. It offers modular, AI-enabled packages with governance and automation, delivering cross-market visibility and scalable insights across the life sciences value chain.

  • Automate Decisions At Scale
    Utilizing advanced AI agents to facilitate decisions that enhance operational efficiency and insights delivery.
  • Enhance Team Collaboration
    Facilitates teamwork and operational synergy across various departments to drive impactful results.
  • Seamlessly Connect Data Systems
    Bridge disparate systems effortlessly for a unified view of data and analytics across platforms.
  • Tailor Solutions To Business Needs
    Start with essential features and expand as your organization grows and evolves.
  • Enhance Compliance Efforts
    Automatic governance features that assist in maintaining compliance and reduce manual workload.
  • Drive Global Operations Effectively
    Equip teams with tools to remain responsive and efficient across multiple markets.

ZS Atlas Intelligence

ZS Atlas Intelligence transforms unstructured consumer feedback into actionable insights by extracting consumer sentiment from online sources and organizing it into themes and actionable paths, enabling faster, unbiased decision-making.

  • Provides Clear Guidance
    Helps businesses identify effective strategies and improvements by aligning insights directly with performance objectives.
  • Captures Real Consumer Voices
    Ensures that businesses understand authentic customer perceptions and sentiments.
  • Streamlines Insight Analysis
    Simplifies the identification of critical insights by categorizing data into actionable themes that resonate with business goals.
  • Accelerates Decision-Making
    With quicker turnaround times, businesses can react swiftly to market trends and consumer needs.
  • Delivers Reliable Insights
    Eliminating bias in data collection fosters trust and reliability in the insights generated.

Personalize.AI

Personalize.AI is an enterprise-grade platform that unifies customer data to power AI-driven personalization at scale, building a 360-degree view of customers by connecting loyalty, interaction and campaign data to drive loyalty, conversions and revenue.

  • Boost Customer Engagement
    Utilizes AI to craft highly relevant offers, increasing customer engagement and driving revenue.
  • Gain Comprehensive Insights
    Compiling customer profiles helps brands better understand behavior and preferences.
  • Automate Content Workflows
    Streamlines content workflows, saving time and enhancing campaign efficiency through automation.
  • Optimize Campaign Performance
    Allows for constant improvement of marketing campaigns, directly linked to CRM data.
  • Enhance Customer Loyalty
    Adapts loyalty tiers and incentives dynamically, increasing customer retention.

Trials.AI

Trials.AI digitizes and optimizes clinical trials with intelligent design, faster data flow, and automation that keeps studies on track.

  • Accelerate Data Access
    Leverages real-time insights to make timely decisions.
  • Streamline Trial Operations
    Reduces the burden of manual tasks and enhances overall trial efficiency.
  • Optimize Study Protocols
    Utilizes intelligent algorithms to design efficient trials.
  • Automate Document Processing
    Reduces processing time and enhances data accuracy.
  • Informed Decision-Making
    Enables quick adaptations based on ongoing trial insights.

References

Methodology and sourcing behind the figures shown above.

Customer data platform

Estimate based on multiple industry reports in the search results. MarketsandMarkets projects a 2025 CDP market size of USD 9.72B (used as the primary market-size figure). Independent reports show 2025 values ranging ~USD 7.37B–11.80B; reported CAGRs for 2025–2030/2032 cluster in the low-to-mid 30% range. I therefore use MarketsandMarkets for market size and a consensus CAGR (33.8%) consistent with The Business Research Company and other forecasts.

Personalization and experience orchestration

Estimate based primarily on multiple market reports in the search results that define the personalization/experience orchestration and customer-journey-orchestration markets. Specialist reports (personalization software and CJO) cluster around USD 11–13 billion in 2024–2025 with reported CAGRs between ~20–25%. AI-orchestration reports show similar high-growth trajectories (~21% CAGR). A much larger figure in one broad AI-personalization report ($484B) reflects a wider definition (all AI-driven personalization use cases) and was used only as context. Therefore the segment-focused estimate is ~USD 12.5B and a mid-point CAGR of ~22.5% (weighted between reported 20.9–24.5%).

Clinical trial automation and optimization

Estimate based on multiple market reports for AI-driven clinical trial solutions/optimization platforms. Specialist reports place the segment between ~USD 1.35–2.79B (2024–2025); InsightAce explicitly values clinical-trial AI optimization platforms at USD 1.97B (2025) and projects a 21.4% CAGR, so I use ~USD 2.0B and a ~21.4% CAGR as a representative midpoint for clinical trial automation and optimization.

Consumer and patient insight analytics

No direct market-size for “consumer and patient insight analytics” in the results. I used comparable markets as proxies: Customer Analytics (USD 15.86B, CAGR ~20.15%), Patient-Generated Health Data (USD 6.8B, CAGR ~17.4%), and the broader Data Analytics market (USD 82.23B, CAGR ~21.5%). Consumer & patient insight analytics is a focused subset spanning healthcare PGHD and general customer analytics (unstructured data, social/listening, patient experience). Combining those proxies and adjusting downward for the niche scope yields an estimated global market ≈ USD 10.0 billion with growth potential around 19% CAGR (consistent with cited 17–21% ranges and accelerating AI/unstructured-data adoption).

Related Organizations